Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription

Nature Communications

Volumn 7, Issue , 2016, Pages

  Kobayashi, Eri H ^a   Suzuki, Takafumi ^a   Funayama, Ryo ^a   Nagashima, Takeshi ^a   Hayashi, Makiko ^a   Sekine, Hiroki ^a,b   Tanaka, Nobuyuki ^c   Moriguchi, Takashi ^a   Motohashi, Hozumi ^b   Nakayama, Keiko ^a   Yamamoto, Masayuki ^a,b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; RNA POLYMERASE II; TRANSCRIPTION FACTOR NRF2; NFE2L2 PROTEIN, MOUSE;

BIOACTIVITY; CELLS AND CELL COMPONENTS; ENZYME; GENE EXPRESSION; IMMUNE RESPONSE; INHIBITION; OXYGEN; PHYSIOLOGICAL RESPONSE; PROTEIN; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE; GENE INDUCTION; GENETIC TRANSCRIPTION; IL6 GENE; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; UPREGULATION; XENOBIOTIC STRESS; ANIMAL; C57BL MOUSE; GENE EXPRESSION REGULATION; INSTITUTE FOR CANCER RESEARCH MOUSE; KNOCKOUT MOUSE; METABOLISM;

MURINAE;

ANIMALS; CYTOKINES; GENE EXPRESSION REGULATION; INFLAMMATION; MACROPHAGES; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; RNA POLYMERASE II;

EID: 84971326395     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11624     Document Type: Article

References (57)

1. Elinav E, et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat. Rev. Cancer. 13, 759-771 (2013
2. Donath M. Y. Targeting inflammation in the treatment of type 2 diabetes: time to start. Nat. Rev. Drug Discov. 13, 465-476 (2014
3. Itoh K, et al An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236, 313-322 (1997
4. Kobayashi E, Suzuki T, & Yamamoto M. Roles nrf2 plays in myeloid cells and related disorders. Oxid. Med. Cell. Longev. 2013, 529219 (2013
5. Itoh K, et al. Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12, 14)-prostaglandin j(2). Mol. Cell. Biol. 24, 36-45 (2004
6. Ishii Y, et al. Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema. J. Immunol. 175, 6968-6975 (2005
7. Iizuka T, et al. Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema. Genes Cells. 10, 1113-1125 (2005
8. Thimmulappa R. K, et al. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J. Clin. Invest. 116, 984-995 (2006
9. Yoh K, et al. Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney Int. 60, 1343-1353 (2001
10. Ma Q, Battelli L, & Hubbs A. F. Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-Activated transcription factor Nrf2 Am. J. Pathol. 168, 1960-1974 (2006
11. Kong X, et al. Enhancing Nrf2 pathway by disruption of Keap1 in myeloid leukocytes protects against sepsis Am. J. Respir. Crit. Care Med. 184, 928-938 (2011
12. Gold R, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N. Engl. J. Med. 367, 1098-1107 (2012
13. Burness C. B, & Deeks E. D. Dimethyl fumarate: a review of its use in patients with relapsing-remitting multiple sclerosis. CNS Drugs. 28, 373-387 (2014
14. Itoh K, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-Terminal Neh2 domain. Genes Dev. 13, 76-86 (1999
15. Suzuki T, Motohashi H, & Yamamoto M. Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol. Sci. 34, 340-346 (2013
16. Kong X, Thimmulappa R, Kombairaju P, & Biswal S. NADPH oxidasedependent reactive oxygen species mediate amplified TLR4 signaling and sepsis-induced mortality in Nrf2-deficient mice. J. Immunol. 185, 569-577 (2010
17. Harvey C. J, et al. Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Sci. Transl. Med. 3, 78ra32 (2011
18. Ishii T, et al. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ. Res. 94, 609-616 (2004
19. Lawrence T, & Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11, 750-761 (2011
20. Okawa H, et al. Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem. Biophys. Res. Commun. 339, 79-88 (2006
21. Clausen B. E, Burkhardt C, Reith W, Renkawitz R, & Förster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265-277 (1999
22. Hirotsu Y, et al. Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks. Nucleic Acids Res. 40, 10228-10239 (2012
23. Rushmore T. H, Morton M. R, & Pickett C. B. The antioxidant responsive element Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 266, 11632-11639 (1991
24. Friling R. S, Bensimon A, Tichauer Y, & Daniel V. Xenobiotic-inducible expression of murine glutathione S-Transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc. Natl Acad. Sci. USA. 87, 6258-6262 (1990
25. Wruck C. J, et al. Nrf2 induces interleukin-6 (IL-6) expression via an antioxidant response element within the IL-6 promoter. J. Biol. Chem. 286, 4493-4499 (2011
26. Kanehisa M, et al. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 42, D199-D205 (2014
27. Tsuchiya S, et al. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer. 26, 171-176 (1980
28. Carpenter S, Ricci E. P, Mercier B. C, Moore M. J, & Fitzgerald K A. Post-Transcriptional regulation of gene expression in innate immunity. Nat. Rev. Immunol. 14, 361-376 (2014
29. Barish G. D, et al. Bcl-6 and NF-kappaB cistromes mediate opposing regulation of the innate immune response. Genes Dev. 24, 2760-2765 (2010
30. Roe J.-S, Mercan F, Rivera K, Pappin D. J, & Vakoc C. R. BET bromodomain inhibition suppresses the function of hematopoietic transcription factors in acute myeloid leukemia. Mol. Cell. 58, 1028-1039 (2015
31. Uhlenhaut N. H, et al. Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. Mol. Cell. 49, 158-171 (2013
32. Katoh Y, et al. Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription. Genes Cells. 6, 857-868 (2001
33. Sekine H, et al. The mediator subunit MED16 transduces NRF2-Activating signals into antioxidant gene expression. Mol. Cell. Biol. 36, 407-420 (2015
34. Hayashi M, et al. Whole-body in vivo monitoring of inflammatory diseases exploiting human interleukin 6-luciferase transgenic mice. Mol. Cell. Biol. 35, 3590-3601 (2015
35. Okuda Y, et al. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int. Immunol. 10, 703-708 (1998
36. Hwang Y.-J, et al. MafK positively regulates NF-kB activity by enhancing CBP-mediated p65 acetylation. Sci. Rep. 3, 3242 (2013
37. Sutton C, Brereton C, Keogh B, Mills K. H. G, & Lavelle E. C A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203, 1685-1691 (2006
38. Pareek T. K, et al. Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitis. Sci. Rep. 1, 201 (2011
39. Li B, et al. Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice. Exp. Neurol. 250, 239-249 (2013
40. Johnson D A, Amirahmadi S, Ward C, Fabry Z, & Johnson J A. The absence of the pro-Antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis. Toxicol. Sci. 114, 237-246 (2010
41. Suzuki T, et al. Regulatory nexus of synthesis and degradation deciphers cellular Nrf2 expression levels. Mol. Cell. Biol. 33, 2402-2412 (2013
42. Mitsuishi Y, et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell. 22, 66-79 (2012
43. Satoh H, et al. Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung. Carcinogenesis. 31, 1833-1843 (2010
44. Hiramoto K, et al. Myeloid lineage-specific deletion of antioxidant system enhances tumor metastasis. Cancer Prev. Res. (Phila) 7, 835-844 (2014
45. Tsukamoto H, Nishikata R, Senju S, & Nishimura Y. Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progression. Cancer Immunol. Res. 1, 64-76 (2013
46. Uruno A, et al. The Keap1-Nrf2 system prevents onset of diabetes mellitus. Mol. Cell. Biol. 33, 2996-3010 (2013
47. Larsen C. M, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356, 1517-1526 (2007
48. Dinarello C A, Simon A, & van der Meer J. W. M. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat. Rev. Drug Discov. 11, 633-652 (2012
49. Taguchi K, et al. Genetic analysis of cytoprotective functions supported by graded expression of Keap1. Mol. Cell. Biol. 30, 3016-3026 (2010
50. Maruyama A, et al. Nrf2 regulates the alternative first exons of CD36 in macrophages through specific antioxidant response elements Arch. Biochem. Biophys. 477, 139-145 (2008
51. Fujita P A, et al. The UCSC Genome Browser database: update 2011. Nucleic Acids Res. 39, D876-D882 (2011
52. Li H, & Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 25, 1754-1760 (2009
53. Li H, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 25, 2078-2079 (2009
54. Zhang Y, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008
55. Quinlan A. R, & Hall I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 26, 841-842 (2010
56. Zhu L. J, et al. ChIPpeakAnno: a bioconductor package to annotate ChIP-seq and ChIP-chip data. BMC Bioinformatics. 11, 237 (2010
57. Cong L, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 339, 819-823 (2013